Category - Executive Moves

Executive Moves

Ironwood appoints Tammi Gaskins as CEO

Ironwood Pharmaceuticals (NASDAQ: IRWD) has announced the appointment of chief commercial officer Tammi Gaskins as CEO and a member of the board of directors, effective January 1, 2027. Current CEO Tom McCourt will...

October 16, 2026

Executive Moves

Jennifer Main joins Claritev’s board

Claritev Corporation (NYSE: CTEV) has appointed Jennifer Main as a director of its board of directors, effective today, filling a newly created directorship on the board. Ms. Main brings more than three decades of...

October 15, 2026

Executive Moves

Valion board chair Thomas Jensen brings biotech turnaround experience to advance Entolimod

Valion Bio (NASDAQ: VBIO) has outlined the perspectives of its new board chair, Thomas H. Jensen, on advancing Entolimod—an investigational Toll-like receptor 5 (TLR5) agonist being developed as a potential medical...

October 5, 2026

Executive Moves

Perimeter appoints finance executive Michelle Caron to BOD

Perimeter Medical Imaging AI (TSX-V: PINK; OTCQX: PYNKF) has announced that Michelle Caron, CPA, has been appointed to its board of directors (BOD), effective immediately. In a finance career spanning more than 28...

October 2, 2026

Executive Moves

Lynn Chapman joins AI/ML as CFO

AI/ML Innovations (CSE: AIML; OTCQB: AIMLF; FWB: 42FB) has appointed Lynn Chapman, CPA, CA, as chief financial officer (CFO), effective October 1, 2026. Mr. Chapman brings more than 15 years of financial and managerial...

October 2, 2026

Executive Moves

Robert DiTota joins Nexalin as senior strategic advisor

Nexalin Technology (NASDAQ: NXL) has announced the appointment of Robert DiTota as senior strategic advisor, global commercialization, effective September 15, 2026. Mr. DiTota brings more than 20 years of neuroscience...

September 29, 2026

Executive Moves

Valion appoints life sciences veteran Dean Zikria as interim CEO and announces board leadership transitions

Valion Bio (NASDAQ: VBIO) has announced the appointment of Dean Zikria as interim CEO, along with leadership changes aimed at strengthening alignment and execution as it advances Entolimod and evaluates strategic...

September 24, 2026

Executive Moves

Q32 Bio names Drs. José Trevejo as CMO and Ellie Hershberger as CDO

Q32 Bio (NASDAQ: QTTB) has announced the appointment of José Trevejo, MD, PhD, as chief medical officer (CMO) and Ellie Hershberger, PharmD, as chief development officer (CDO). Prior to joining Q32 Bio, Dr. Trevejo...

September 14, 2026

Executive Moves

Chris Benecchi joins Inventiva as COO

Inventiva (Euronext Paris and NASDAQ: IVA) has announced the appointment of biopharmaceutical leader Chris Benecchi as chief operating officer (COO). Mr. Benecchi brings 30 years of biopharmaceutical leadership across...

September 2, 2026

Executive Moves

Valion announces changes to management and BOD

Valion Bio (NASDAQ: VBIO) has announced that its current chief financial officer, Lisa Wolf, has also been named president and chief operating officer, effective immediately, following the departure of former chief...

September 1, 2026

Category - Executive Moves

Subscribe